Locations:
Abu Dhabi|Canada|Florida|London|Nevada|Ohio|
Gray gradientGray gradient
Cleveland Clinic icon
Consult QD logo
Search IconSearch

Research

19-NEU-3925-stereotactic-radiosurgery-brain-mets-650×450
September 16, 2019/Cancer

High-Dose Neoadjuvant Radiosurgery for Brain Metastases Appears Safe, Effective in Early Results from Phase 1/2 Study

Dose-escalation trial shows local control with low toxicity, low leptomeningeal recurrence

Figure7
September 10, 2019/Neurosciences/Research

Augmented Reality System for Evaluating Post-mTBI Combat Readiness Promises Clinical Payoffs Too

DoD grant supports creation, validation of multidimensional field assessments

19-NEU-3934-glioblastoma-ADAMDEC1-450×650

Novel Pathway Critical to Glioma Stem Cells Identified as Therapeutic Target in Glioblastoma

Newly discovered signaling loop is shown to be druggable

18-NEU-5689 Alzheimers-brain-650×450
August 22, 2019/Geriatrics

Lenalidomide for Early Alzheimer’s: Taking on Multiple Neuropathologies at Once

New clinical trials size up an immunomodulator’s pleiotropic effects

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

19-NEU-3900-immunotherapy-650×450
August 20, 2019/Cancer

Immunotherapy for Non-Small Cell Lung Cancer Brain Metastases: Ready for Prime Time

Companion studies reveal efficacy indicators for PD-1/PD-L1 inhibition

Epilepsy testing

Integrated Studies Focus in on Optimal Prediction of Epilepsy Treatment Response

Grant enables pooling of genomics, molecular medicine, animal models, advanced neuroimaging

19-NEU-3855-Exoskeleton-650×450
July 31, 2019/Neurosciences/Research

Piloting a Powered Exoskeleton for Gait Training in Multiple Sclerosis

New study aims to assess a potential new indication for the technology

19-NEU-4042-social-buzz-650×450

Can Social Media Buzz Increase Your Academic Citations?

Study looks for correlations in neurology research

Justin Lathia, MD

Grant Boosts Efforts to Take on Glioblastoma by Targeting Immunosuppressive Cells

Focus is on inhibiting action of myeloid-derived suppressor cells

Self-portrait
July 15, 2019/Neurosciences/Research

Tardive Dyskinesia Therapy Holds Up Over Long-Term Assessment

Extension study of VMAT2 inhibitor helps confirm a new therapeutic era

BackPage 8 of 17Next

Advertisement

Ad